Myriad Genetics Cash Conversion Cycle 2011-2026 | MYGN

Annual Cash Conversion Cycle Myriad Genetics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
45.1	42.6	31.1	47.8	136	49.8	65.3	95.7	85.9	54.2	42.7	-2.01	54.5	1.41

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
136	-2.01	53.6

Quarterly Cash Conversion Cycle Myriad Genetics

2025-Q3	2025-Q2	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
54.8	50.1	-	44.5	39.8	43.8	-	33.3	32.1	37.5	-	20.8	15.3	28.9	-	51.4	45.5	48.4	52.8	56.2	87.6	65.3	55	61.5	62.6	61.4	49.6	49.3	41.9	78.5	90.8	94.7	48.1	108	124	117	84.5	84.9	81.2	75.3	51.2	52.4	41.9	42.4	42.5	21.4	-24.7	-16.5	-6.18	8.27	31.7	45.1	45.4	44.7	37.2	25.9	14.7	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
124	-24.7	49.7

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
Burning Rock Biotech Limited BNR	149	$ 23.45	0.63 %	$ 252 M	China
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Co-Diagnostics CODX	299	$ 5.98	-3.39 %	$ 175 M	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Castle Biosciences CSTL	45.9	$ 39.66	0.81 %	$ 1.1 B	USA
DexCom DXCM	133	$ 70.98	5.31 %	$ 27.4 B	USA
BioNano Genomics BNGO	225	$ 1.59	0.63 %	$ 2.02 M	USA
Guardant Health GH	49.1	$ 107.57	-2.36 %	$ 13.2 B	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Illumina ILMN	142	$ 145.55	3.18 %	$ 23.1 B	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
IQVIA Holdings IQV	78	$ 240.86	-0.66 %	$ 43.7 B	USA
CareDx, Inc CDNA	76.4	$ 20.57	20.08 %	$ 1.11 B	USA
Danaher Corporation DHR	83.5	$ 239.0	0.27 %	$ 175 B	USA
DarioHealth Corp. DRIO	207	$ 11.67	-4.03 %	$ 331 M	Israel
Anixa Biosciences ANIX	275	$ 3.16	-6.51 %	$ 103 K	USA
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Lantheus Holdings LNTH	90.9	$ 67.48	-0.12 %	$ 4.67 B	USA
Exact Sciences Corporation EXAS	130	$ 102.23	0.12 %	$ 18.9 B	USA
Medpace Holdings MEDP	51.5	$ 599.21	0.71 %	$ 18.5 B	USA
Fulgent Genetics FLGT	42.4	$ 28.16	1.11 %	$ 851 M	USA
Aspira Women's Health AWH	-38.7	-	-6.19 %	$ 10.5 M	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
National Research Corporation NRC	33	$ 20.43	3.6 %	$ 501 M	USA
Natera NTRA	81.5	$ 235.45	0.49 %	$ 23.2 B	USA
OPKO Health OPK	242	$ 1.33	-2.21 %	$ 923 M	USA
Pacific Biosciences of California PACB	149	$ 2.01	3.61 %	$ 510 M	USA
Charles River Laboratories International CRL	67.7	$ 218.82	-0.95 %	$ 11.2 B	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
Personalis PSNL	-11.5	$ 8.57	5.8 %	$ 508 M	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Mettler-Toledo International MTD	63.7	$ 1 491.99	0.46 %	$ 31.7 B	Schweiz
ENDRA Life Sciences NDRA	-1.24 K	$ 4.53	-2.58 %	$ 2.43 M	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
Neogen Corporation NEOG	150	$ 9.37	-2.6 %	$ 2.03 B	USA
Quest Diagnostics Incorporated DGX	38.6	$ 175.94	0.85 %	$ 19.5 B	USA
Biodesix BDSX	41.7	$ 8.08	47.99 %	$ 1.05 B	USA
Organovo Holdings ONVO	-82.8 K	-	-2.3 %	$ 19.4 M	USA